Pancreatic cancer genes
The present invention provides the art with the DNA coding sequences of polynucleotides that are up-or-down-regulated in cancer and dysplasia. These polynucleotides and encoded proteins or polypeptides can be used in the diagnosis or identification of cancer and dysplasia. Inhibitors of the up-regulated polynucleotides and proteins can decrease the abnormality of cancer and dysplasia. Enhancing the expression of down-regulated polynucleotides or introducing down-regulated proteins to cells can decrease the growth and/or abnormal characteristics of cancer and dysplasia.
1. An isolated polypeptide comprising at least 6 contiguous amino acids encoded by SEQ ID NO:2.
2. The isolated polypeptide of claim 1 , wherein said polypeptide comprises at least 10 contiguous amino acids encoded by SEQ ID NO:2.
3. The isolated polypeptide of claim 1 , wherein said polypeptide comprises at least 15 contiguous amino acids encoded by SEQ ID NO:2.
4. The isolated polypeptide of claim 1 , wherein said polypeptide comprises at least 20 contiguous amino acids encoded by SEQ ID NO:2.
5. The isolated polypeptide of claim 1 , wherein said polypeptide comprises at least 30 contiguous amino acids encoded by SEQ ID NO:2.
6. An isolated polypeptide comprising a first protein segment comprising at least 6 contiguous amino acids encoded by SEQ ID NO:2; and a second protein segment.
7. The isolated polypeptide of claim 6 , wherein said second protein segment is an enzyme.
8. The isolated polypeptide of claim 6 , wherein said second protein segment is labeled with a detectable marker.